This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Sep;81(14):1691-1692.

doi: 10.1007/s40265-021-01582-2. Epub 2021 Aug 28.

Comment on: "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19"

Song Zhang¹, Feng Zhu²

Affiliations

Affiliations

¹ College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
² College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. zhufeng@zju.edu.cn.

PMID: 34453690
PMCID: PMC8397856
DOI: 10.1007/s40265-021-01582-2

Comment

Comment on: "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19"

Song Zhang et al. Drugs. 2021 Sep.

. 2021 Sep;81(14):1691-1692.

doi: 10.1007/s40265-021-01582-2. Epub 2021 Aug 28.

Authors

Song Zhang¹, Feng Zhu²

Affiliations

¹ College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
² College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. zhufeng@zju.edu.cn.

PMID: 34453690
PMCID: PMC8397856
DOI: 10.1007/s40265-021-01582-2

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment in

Reply to Zhang and Zhu "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
Ahmed N, Pezacki JP. Ahmed N, et al. Drugs. 2021 Sep;81(14):1693-1695. doi: 10.1007/s40265-021-01581-3. Epub 2021 Aug 28. Drugs. 2021. PMID: 34453691 Free PMC article. No abstract available.

Comment on

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
Hum C, Loiselle J, Ahmed N, Shaw TA, Toudic C, Pezacki JP. Hum C, et al. Drugs. 2021 Apr;81(5):517-531. doi: 10.1007/s40265-021-01474-5. Epub 2021 Feb 27. Drugs. 2021. PMID: 33638807 Free PMC article. Review.

Similar articles

Reply to Zhang and Zhu "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
Ahmed N, Pezacki JP. Ahmed N, et al. Drugs. 2021 Sep;81(14):1693-1695. doi: 10.1007/s40265-021-01581-3. Epub 2021 Aug 28. Drugs. 2021. PMID: 34453691 Free PMC article. No abstract available.
Therapeutic Agents Against COVID-19 with Clinical Evidence.
Tian C, Xiang M. Tian C, et al. Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951. Curr Pharm Des. 2021. PMID: 33459226 Review.
The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic.
Kumar R, Harilal S, Al-Sehemi AG, Mathew GE, Carradori S, Mathew B. Kumar R, et al. Curr Med Chem. 2021;28(15):2852-2886. doi: 10.2174/0929867327666200702151018. Curr Med Chem. 2021. PMID: 32614740
[Umifenovir and coronavirus infections: a review of research results and clinical practice].
Leneva IA, Pshenichnaya NY, Bulgakova VA. Leneva IA, et al. Ter Arkh. 2020 Dec 26;92(11):91-97. doi: 10.26442/00403660.2020.11.000713. Ter Arkh. 2020. PMID: 33720612 Review. Russian.
Comment on: Favipiravir, an antiviral for COVID-19?
Chachaima-Mar J, Pérez-Castilla J. Chachaima-Mar J, et al. J Antimicrob Chemother. 2021 Jan 1;76(1):279-280. doi: 10.1093/jac/dkaa378. J Antimicrob Chemother. 2021. PMID: 32888000 Free PMC article. No abstract available.

See all similar articles

Cited by

HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies.
Bartoszewska S, Sławski J, Collawn JF, Bartoszewski R. Bartoszewska S, et al. Cancers (Basel). 2023 May 25;15(11):2903. doi: 10.3390/cancers15112903. Cancers (Basel). 2023. PMID: 37296866 Free PMC article. Review.
RNA Therapeutics: Focus on Antisense Oligonucleotides in the Nervous System.
Ertural B, Çiçek BN, Kurnaz IA. Ertural B, et al. Biomol Ther (Seoul). 2025 Jul 1;33(4):572-581. doi: 10.4062/biomolther.2025.022. Epub 2025 Jun 19. Biomol Ther (Seoul). 2025. PMID: 40534528 Free PMC article. Review.
Trials and Tribulations of MicroRNA Therapeutics.
Seyhan AA. Seyhan AA. Int J Mol Sci. 2024 Jan 25;25(3):1469. doi: 10.3390/ijms25031469. Int J Mol Sci. 2024. PMID: 38338746 Free PMC article. Review.
SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs.
Rasizadeh R, Aghbash PS, Nahand JS, Entezari-Maleki T, Baghi HB. Rasizadeh R, et al. Virol J. 2023 Aug 9;20(1):179. doi: 10.1186/s12985-023-02152-6. Virol J. 2023. PMID: 37559103 Free PMC article. Review.
Non-coding RNAs as potential targets in metformin therapy for cancer.
Zhang Y, Wu Y, Liu Z, Yang K, Lin H, Xiong K. Zhang Y, et al. Cancer Cell Int. 2024 Oct 1;24(1):333. doi: 10.1186/s12935-024-03516-w. Cancer Cell Int. 2024. PMID: 39354464 Free PMC article. Review.

See all "Cited by" articles

References

1. Hum C, et al. MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs. 2021;81(5):517–531. doi: 10.1007/s40265-021-01474-5. - DOI - PMC - PubMed
1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854. doi: 10.1016/0092-8674(93)90529-Y. - DOI - PubMed
1. Mullard A. 2018 FDA drug approvals. Nat Rev Drug Discov. 2019;18(2):85–89. doi: 10.1038/d41573-019-00014-x. - DOI - PubMed
1. Mullard A. 2019 FDA drug approvals. Nat Rev Drug Discov. 2020;19(2):79–84. doi: 10.1038/d41573-020-00001-7. - DOI - PubMed
1. Mullard A. 2020 FDA drug approvals. Nat Rev Drug Discov. 2021;20(2):85–90. doi: 10.1038/d41573-021-00002-0. - DOI - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

81872798/National Natural Science Foundation of China

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information